After a certain threshold has been reached, EGR1 is no longer able to compensate sufficiently given the synaptotoxic consequences of Aβ, and cognitive impairment associated with the symptomatic stage of AD is thought to commence. Here, EGR1 is linked to Cognitive impairment.